These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 20272825)

  • 1. Methionine in the treatment of chronic and acute hepatitis.
    STEIGMANN F; SALK M
    Proc Annu Meet Cent Soc Clin Res U S; 1947; 20():63. PubMed ID: 20272825
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of d-1-methionin in metabolism of the diseased liver; effect of methionin in acute liver failure and on the N-balance in hepatitis].
    HARTMANN F
    Dtsch Arch Klin Med; 1949; 196(5):412-31. PubMed ID: 15405959
    [No Abstract]   [Full Text] [Related]  

  • 3. Methionine in the treatment of acute hepatitis.
    STROM J
    Br Med J; 1950 May; 1(4663):1168-9. PubMed ID: 15420427
    [No Abstract]   [Full Text] [Related]  

  • 4. Has methionine a protein sparing effect in acute infectious hepatitis?
    POPPER H; KOZOLL DD
    Am J Med Sci; 1948 Jun; 215(6):624-30. PubMed ID: 18875451
    [No Abstract]   [Full Text] [Related]  

  • 5. [Experiences with hepsan, a new methionine-choline preparation, in treatment of acute epidemic hepatitis].
    GORS H; KIRNBERGER EJ
    Munch Med Wochenschr; 1950 Jul; 92(13-14):533-7. PubMed ID: 15439012
    [No Abstract]   [Full Text] [Related]  

  • 6. [ACTION OF ASPARTIC ACID ON THE METABOLISM OF METHIONINE S35 IN CHRONIC HEPATITIS].
    SZANTAI I; FARCASANU M; FODOR O; COTUL S
    Rev Int Hepatol; 1963; 13():429-39. PubMed ID: 14113343
    [No Abstract]   [Full Text] [Related]  

  • 7. [Intestinal absorption of S-35-methionine in chronic hepatitis].
    WARTER J; METAIS P; WERYHA A; SACREZ A; SCHIRARDIN H
    Pathol Biol; 1961 Sep; 9():1769-71. PubMed ID: 14005082
    [No Abstract]   [Full Text] [Related]  

  • 8. [RESEARCH CONCERNING CERTAIN METABOLIC MODIFICATIONS OF METHIONINE IN EPIDEMIC HEPATITIS].
    SZANTAI I; HOLAN T; FARCASANU M; ABRUDAN R; GIDALI M; ONESCIUC I; GAVRILA I
    Rev Int Hepatol; 1964; 14():655-69. PubMed ID: 14276969
    [No Abstract]   [Full Text] [Related]  

  • 9. [FURTHER CLINICAL AND BIOCHEMICAL VERIFICATIONS OF THE THERAPEUTIC ACTION OF ASPARTIC ACID IN CHRONIC HEPATITIS].
    FODOR O; SURIANU P; TRAGOR S; COTUL S; SZANTAY I; HOLAN T; FARCASAN M
    Med Interna (Bucur); 1963 Apr; 15():463-72. PubMed ID: 14050906
    [No Abstract]   [Full Text] [Related]  

  • 10. [Evaluation of the effectiveness of methionine in the treatment of Botkin's disease].
    KORNILOVA II; IARTSEVA AM
    Sov Med; 1961 May; 25():63-9. PubMed ID: 13753221
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of methionine and sugar on the liver in experimental toxipathic hepatitis in the rat].
    REMY R; GERLICH N
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1951; 212(5-6):542-5. PubMed ID: 14847614
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of choline and methionine, testosterone propionate, and dietary protein on nitrogen balance in patients with liver disease.
    GABUZDA GJ; ECKHARDT RD; DAVIDSON CS
    J Clin Invest; 1950 May; 29(5):566-76. PubMed ID: 15415461
    [No Abstract]   [Full Text] [Related]  

  • 13. [Consideration on hepatitis therapy].
    KLEIN K; BUHLER F
    Arztl Wochensch; 1951 Jul; 6(28):66-9. PubMed ID: 14856871
    [No Abstract]   [Full Text] [Related]  

  • 14. [Lipotropic substances in the treatment of liver disease].
    CZECH W
    Med Klin; 1950 Jun; 45(24):753-7. PubMed ID: 15438559
    [No Abstract]   [Full Text] [Related]  

  • 15. [TREATMENT OF SERUM HEPATITIS].
    UEDA H; HARADA T
    Naika; 1964 Jul; 14():83-6. PubMed ID: 14174362
    [No Abstract]   [Full Text] [Related]  

  • 16. The effects of lipotropic factors on the phospholipide turnover in patients with infectious hepatitis.
    CAYER D; CORNATZER WE
    Gastroenterology; 1951 May; 18(1):79-85. PubMed ID: 14840587
    [No Abstract]   [Full Text] [Related]  

  • 17. Serum and urinary methionine concentrations in severe hepatic failure of viral hepatitis. Relevance to development of encephalopathy and prognosis.
    Kaldor J; Spelman DW; Metcalf WR; Lucas CR
    Med J Aust; 1986 Jul; 145(2):76-9. PubMed ID: 3736469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Critical comments on therapy of hepatitis with lipotropic substances].
    STAHL I
    Arztl Wochensch; 1952 Oct; 7(43):1010-4. PubMed ID: 12996377
    [No Abstract]   [Full Text] [Related]  

  • 19. [COMPARATIVE EXPERIMENTAL STUDY OF THE HEPATOPROTECTOR CAPACITY OF CERTAIN BETAINE, CHOLINE AND METHIONINE DERIVATIVES].
    SAVEL J; LEROI E
    Pathol Biol; 1964; 12():718-22. PubMed ID: 14187720
    [No Abstract]   [Full Text] [Related]  

  • 20. [Differentiation between fulminant hepatitis and the severe form of acute hepatitis: usefulness of plasma methionine].
    Kato A
    Nihon Shokakibyo Gakkai Zasshi; 1983 May; 80(5):1224. PubMed ID: 6632330
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.